-+ 0.00%
-+ 0.00%
-+ 0.00%

VIR BIOTECHNOLOGY INC: POSITIVE, UPDATED PHASE 2 SOLSTICE DATA SHOWED COMBINATION OF TOBEVIBART AND ELEBSIRAN IS WELL TOLERATED

Reuters·01/12/2026 13:00:05

Please log in to view news